NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow Coral Corp.’s (OTCBB: RBCC) biotech subsidiary, Rainbow BioSciences LLC, pursues promising new opportunities in the field of neurodegenerative medicine, demand for effective new treatments for diseases such as Parkinson’s and Alzheimer’s are growing by the day. Global Industry Analysts, Inc. (GIA) predicts that the global market for neurodegenerative drugs and treatments will exceed $43.4 billion by 2015.
